Van Plew Daniel P's Form 4 filing
Regeneron Pharmaceuticals, Inc. (REGN) · filed Feb 24, 2022
- Accession no.
- 0001708138-22-000018
- Filed
- Feb 24, 2022
- Trade date
- Feb 22-23, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 13 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.16M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Van Plew Daniel PCIK 0001411984 | Officer (EVP & General Mgr, Industrial) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 22, 2022 | Common Stock | MOption exerciseAcquired | +40,000 | $399.66 | +$15,986,400 | 70,578 | Direct | |
| Feb 22, 2022 | Common Stock | FTax withholdingDisposed | −33,219 | $610.56 | −$20,282,192.64 | 37,359 | Direct | |
| Feb 23, 2022 | Common Stock | SSaleDisposed | −156 | $607.94F1 | −$94,838.64 | 37,203 | Direct | |
| Feb 23, 2022 | Common Stock | SSaleDisposed | −800 | $608.29F2 | −$486,632 | 36,403 | Direct | |
| Feb 23, 2022 | Common Stock | SSaleDisposed | −400 | $609.62F3 | −$243,848 | 36,003 | Direct | |
| Feb 23, 2022 | Common Stock | SSaleDisposed | −200 | $610.41F4 | −$122,082 | 35,803 | Direct | |
| Feb 23, 2022 | Common Stock | SSaleDisposed | −800 | $611.65F5 | −$489,320 | 35,003 | Direct | |
| Feb 23, 2022 | Common Stock | SSaleDisposed | −600 | $612.44F6 | −$367,464 | 34,403 | Direct | |
| Feb 23, 2022 | Common Stock | SSaleDisposed | −600 | $614.53F7 | −$368,718 | 33,803 | Direct | |
| Feb 23, 2022 | Common Stock | SSaleDisposed | −300 | $615.20F8 | −$184,560 | 33,503 | Direct | |
| Feb 23, 2022 | Common Stock | SSaleDisposed | −734 | $616.40F9 | −$452,437.6 | 32,769 | Direct | |
| Feb 23, 2022 | Common Stock | SSaleDisposed | −1,176 | $617.48F10 | −$726,156.48 | 31,593 | Direct | |
| Feb 23, 2022 | Common Stock | SSaleDisposed | −1,015 | $618.16F11 | −$627,432.4 | 30,578 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 22, 2022 | Common Stock | MOption exerciseDisposed | −40,000 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents volume-weighted average price of sales of 156 shares of Company stock on February 23, 2022 at prices ranging from $607.92 to $607.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F2
Represents volume-weighted average price of sales of 800 shares of Company stock on February 23, 2022 at prices ranging from $608.01 to $608.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents volume-weighted average price of sales of 400 shares of Company stock on February 23, 2022 at prices ranging from $609.59 to $609.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents volume-weighted average price of sales of 200 shares of Company stock on February 23, 2022 at prices ranging from $610.30 to $610.52. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents volume-weighted average price of sales of 800 shares of Company stock on February 23, 2022 at prices ranging from $611.30 to $611.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents volume-weighted average price of sales of 600 shares of Company stock on February 23, 2022 at prices ranging from $612.03 to $612.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Represents volume-weighted average price of sales of 600 shares of Company stock on February 23, 2022 at prices ranging from $614.02 to $614.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F8
Represents volume-weighted average price of sales of 300 shares of Company stock on February 23, 2022 at prices ranging from $615.03 to $615.52. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F9
Represents volume-weighted average price of sales of 734 shares of Company stock on February 23, 2022 at prices ranging from $616.14 to $616.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F10
Represents volume-weighted average price of sales of 1,176 shares of Company stock on February 23, 2022 at prices ranging from $617.06 to $617.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F11
Represents volume-weighted average price of sales of 1,015 shares of Company stock on February 23, 2022 at prices ranging from $618.00 to $618.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.